JADE BIOSCIENCES INC (JBIO) Forecast, Price Target & Analyst Ratings

NASDAQ:JBIO • US0080642061

Current stock price

13.89 USD
-0.11 (-0.79%)
At close:
13.89 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JADE BIOSCIENCES INC (JBIO).

Forecast Snapshot

Consensus Price Target

Price Target
$22.44
+ 61.56% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.49
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
88.57%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.44
Upside
+ 61.56%
From current price of $13.89 to mean target of $22.44, Based on 14 analyst forecasts
Low
$16.16
Median
$24.48
High
$29.40

Price Target Revisions

1 Month
0.00%
3 Months
6.45%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for JBIO. The average price target is 22.44 USD. This implies a price increase of 61.56% is expected in the next year compared to the current price of 13.89.
The average price target has been revised upward by 6.45% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

JBIO Current Analyst RatingJBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

JBIO Historical Analyst RatingsJBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
88.57%
JBIO was analyzed by 14 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about JBIO.
In the previous month the buy percentage consensus was at a similar level.
JBIO was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16BTIGMaintains Buy -> Buy
2026-03-11GuggenheimMaintains Buy -> Buy
2026-03-09WedbushReiterate Outperform -> Outperform
2026-01-07HC Wainwright & Co.Initiate Buy
2025-11-25Clear StreetInitiate Buy
2025-11-18GuggenheimMaintains Buy -> Buy
2025-10-09BTIGInitiate Buy
2025-08-14WedbushMaintains Outperform -> Outperform
2025-06-16GuggenheimUpgrade Neutral -> Buy
2025-05-15WedbushReiterate Outperform -> Outperform
2025-05-07WedbushInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.49
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
84.45%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
1.04%
EPS (3 Months)
3.73%

Next Earnings Summary

JBIO is expected to report earnings on 4/20/2026. The consensus EPS estimate for the next earnings is -0.49 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
JBIO revenue by date.JBIO revenue by date.
N/AN/AN/AN/AN/AN/AN/A
EBITDA
YoY % growth
JBIO ebitda by date.JBIO ebitda by date.
-3.33M-8.89M
-166.97%		-23M
-158.72%		-53.17M
-131.17%		-81.313M
-52.93%		-74.014M
8.98%		-113.516M
-53.37%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
JBIO ebit by date.JBIO ebit by date.
-3.33M-8.89M
-166.97%		-23.02M
-158.94%		-53.24M
-131.28%		-81.409M
-52.91%		-74.296M
8.74%		-113.542M
-52.82%		N/A
-31.80%		N/A
-10.50%		N/A
-8.95%		N/A
85.06%		N/A
-2.70%		N/A
-2.73%		N/A
-2.74%
Operating Margin
JBIO operating margin by date.JBIO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
JBIO eps by date.JBIO eps by date.
N/AN/AN/A-73.85
-28.69%		-100.80
-36.49%		-85.40
15.28%		-5.08
94.05%		N/A
61.57%		N/A
-7.89%		N/A
-28.55%		N/A
-13.18%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.49
84.45%		-0.50
41.62%		-0.53
-9.74%		-0.58
2.53%		-0.40
19.19%		-0.41
18.12%		-0.38
28.54%		-0.40
31.12%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-35.741M
-955.25%		-29.797M
-7.27%		-30.956M
-12.97%		-32.564M
6.90%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

JBIO Yearly EPS VS EstimatesJBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.63%
EPS Next 5 Year
8.71%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

JADE BIOSCIENCES INC / JBIO Forecast FAQ

Can you provide the average price target for JADE BIOSCIENCES INC stock?

14 analysts have analysed JBIO and the average price target is 22.44 USD. This implies a price increase of 61.56% is expected in the next year compared to the current price of 13.89.

What is the next earnings date for JBIO stock?

JADE BIOSCIENCES INC (JBIO) will report earnings on 2026-04-20, before the market open.

Can you provide the consensus estimates for JADE BIOSCIENCES INC next earnings?

The consensus EPS estimate for the next earnings of JADE BIOSCIENCES INC (JBIO) is -0.49 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for JADE BIOSCIENCES INC stock?

The consensus rating for JADE BIOSCIENCES INC (JBIO) is 88.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.